The cell adhesion molecule L1 promotes gallbladder carcinoma progression in vitro and in vivo

Oncology Reports

Volumn 25, Issue 4, 2011, Pages 945-952

  Jung, Juyeon ^a   Son, Yeon Sung ^a   Park, Hongryeol ^b   Jeon, Seong Kook ^a   Lee, Jung Whoi ^a   Choi, Song Yi ^c   Kim, Jin Man ^c   Kwon, Young Guen ^b   Hong, Hyo Jeong ^d   Min, Jeong Ki ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Yonsei University   (South Korea)

^c Chungnam National University   (South Korea)

^d Kangwon National University   (South Korea)

Author keywords

Gallbladder carcinoma; L1 cell adhesion molecule; Therapeutic target; Tumor progression

Indexed keywords

FOCAL ADHESION KINASE; LENTIVIRUS VECTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NERVE CELL ADHESION MOLECULE L1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENICITY; CARCINOMA CELL; CELL ADHESION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GALLBLADDER CARCINOMA; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ADENOCARCINOMA; ANIMALS; BLOTTING, WESTERN; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; FOCAL ADHESION KINASE 1; GALLBLADDER NEOPLASMS; HUMANS; LENTIVIRUS; MICE; MICE, NUDE; NEURAL CELL ADHESION MOLECULE L1; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING;

EID: 79952222516     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1181     Document Type: Article

References (33)

1. Miller G and Jarnagin WR: Gallbladder carcinoma. Eur J Surg Oncol 34: 306-312, 2008. (Pubitemid 351312864)
2. Randi G, Franceschi S and La Vecchia C: Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 118: 1591-1602, 2006. (Pubitemid 43376420)
3. Misra S, Chaturvedi A, Misra NC and Sharma ID: Carcinoma of the gallbladder. Lancet Oncol 4: 167-176, 2003.
4. Grobmyer SR, Lieberman MD and Daly JM: Gallbladder cancer in the twentieth century: single institution's experience. World J Surg 28: 47-49, 2004.
5. Serra I, Calvo A, Baez S, Yamamoto M, Endoh K and Aranda W: Risk factors for gallbladder cancer. An international collaborative case-control study. Cancer 78: 1515-1517, 1996.
6. Finas D, Huszar M, Agic A, et al: L1 cell adhesion molecule (L1CAM) as a pathogenetic factor in endometriosis. Hum Reprod 23: 1053-1062, 2008. (Pubitemid 351757314)
7. Lindner J, Rathjen FG and Schachner M: L1 mono- and polyclonal antibodies modify cell migration in early postnatal mouse cerebellum. Nature 305: 427-430, 1983. (Pubitemid 14225148)
8. Asou H, Miura M, Kobayashi M and Uyemura K: The cell adhesion molecule L1 has a specific role in neural cell migration. Neuroreport 3: 481-484, 1992.
9. Pancook JD, Reisfeld RA, Varki N, Vitiello A, Fox RI and Montgomery AM : Expression and regulation of the neural cell adhesion molecule L1 on human cells of myelomonocytic and lymphoid origin. J Immunol 158: 4413-4421, 1997. (Pubitemid 127483945)
10. Nolte C, Moos M and Schachner M: Immunolocalization of the neural cell adhesion molecule L1 in epithelia of rodents. Cell Tissue Res 298: 261-273, 1999. (Pubitemid 29512078)
11. Gavert N, Ben-Shmuel A, Raveh S and Ben-Ze'ev A: L1-CAM in cancerous tissues. Expert Opin Biol Ther 8: 1749-1757, 2008.
12. Huszar M, Moldenhauer G, Gschwend V, Ben-Arie A, Altevogt P and Fogel M: Expression profile analysis in multiple human tumors identifies L1 (CD171) as a molecular marker for differential diagnosis and targeted therapy. Hum Pathol 37: 1000-1008, 2006. (Pubitemid 44097029)
13. Li S, Jo YS, Lee JH, et al: L1 cell adhesion molecule is a novel independent poor prognostic factor of extrahepatic cholangiocarcinoma. Clin Cancer Res 15: 7345-7351, 2009.
14. Raveh S, Gavert N and Ben-Ze'ev A: L1 cell adhesion molecule (LlCAM) in invasive tumors. Cancer Lett 282: 137-145, 2009.
15. Schaefer AW, Kamiguchi H, Wong EV, Beach CM, Landreth G and Lemmon V: Activation of the MAPK signal cascade by the neural cell adhesion molecule L1 requires L1 internalization. J Biol Chem 274: 37965-37973, 1999. (Pubitemid 30026865)
16. Silletti S, Yebra M, Perez B, Cirulli V, McMahon M and Montgomery AM: Extracellular signal-regulated kinase (ERK)-dependent gene expression contributes to L1 cell adhesion molecule-dependent motility and invasion. J Biol Chem 279: 28880-28888, 2004. (Pubitemid 38915755)
17. Villedieu M, Deslandes E, Duval M, Heron JF, Gauduchon P and Poulain L: Acquisition of chemoresistance following discontinuous exposures to cisplatin is associated in ovarian carcinoma cells with progressive alteration of FAK, ERK and p38 activation in response to treatment. Gynecol Oncol 101: 507-519, 2006. (Pubitemid 44251068)
18. Loers G, Chen S, Grumet M and Schachner M: Signal transduction pathways implicated in neural recognition molecule L1 triggered neuroprotection and neuritogenesis. J Neurochem 92: 1463-1476, 2005. (Pubitemid 40389215)
19. Thelen K, Kedar V, Panicker AK, Schmid RS, Midkiff BR and Maness PF: The neural cell adhesion molecule L1 potentiates integrin-dependent cell migration to extracellular matrix proteins. J Neurosci 22: 4918-4931, 2005.
20. Mechtersheimer S, Gutwein P, Agmon-Levin N, et al: Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. J Cell Biol 155: 661-673, 2001. (Pubitemid 34289323)
21. Kulahin N, Li S, Hinsby A, Kiselyov V, Berezin V and Bock E: Fibronectin type III (FN3) modules of the neuronal cell adhesion molecule L1 interact directly with the fibroblast growth factor (FGF) receptor. Mol Cell Neurosci 37: 528-536, 2008.
22. Gast D, Riedle S, Schabath H, et al: L1 augments cell migration and tumor growth but not beta3 integrin expression in ovarian carcinomas. Int J Cancer 115: 658-665, 2005. (Pubitemid 40656727)
23. Gavert N, Sheffer M, Raveh S, et al: Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis. Cancer Res 67: 7703-7712, 2007. (Pubitemid 47281363)
24. Gutwein P, Stoeck A, Riedle S, et al: Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells. Clin Cancer Res 11: 2492-24501, 2005.
25. Hasumura S, Nagamori S, Fujise K, et al: Combination therapy of hyperthermia and other methods in liver and bile tract cancers - evaluation of these methods using cancer cell lines in vitro. Gan To Kagaku Ryoho 16: 1905-1912, 1989.
26. Ku JL, Yoon KA, Kim IJ, et al: Establishment and characterisation of six human biliary tract cancer cell lines. Br J Cancer 87: 187-193, 2002.
27. Takeda Y, Asou H, Murakami Y, Miura M, Kobayashi M and Uyemura K: A non-neuronal isoform of cell adhesion molecule L1: tissue-specific expression and functional analysis. J Neurochem 66: 2338-2349, 1996. (Pubitemid 26159068)
28. Linnemann D and Bock E: Expression of the cell adhesion molecules N-CAM and L1 in B16 melanoma cells. Med Biol 64: 345-349, 1986. (Pubitemid 17226777)
29. Fogel M, Gutwein P, Mechtersheimer S, et al: L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas. Lancet 362: 869-875, 2003. (Pubitemid 37130096)
30. Allory Y, Matsuoka Y, Bazille C, Christensen EI, Ronco P and Debiec H: The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas. Clin Cancer Res 11: 1190-1197, 2005. (Pubitemid 40175770)
31. Min JK, Kim JM, Li S, et al: L1 cell adhesion molecule is a novel therapeutic target in intrahepatic cholangiocarcinoma. Clin Cancer Res 16: 3571-3580, 2010.
32. Arlt MJ, Novak-Hofer I, Gast D, et al: Efficient inhibition of intraperitoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment. Cancer Res 66: 936-943, 2006. (Pubitemid 43165961)
33. Knogler K, Grunberg J, Zimmermann K, et al: Copper-67 radioimmunotherapy and growth inhibition by anti-L1-cell adhesion molecule monoclonal antibodies in a therapy model of ovarian cancer metastasis. Clin Cancer Res 13: 603-611, 2007. (Pubitemid 46225367)